Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 08/14/2024, with an aggregate market value of $95,251.36. The shares were acquired through stock option exercises on 06/14/2023 and 07/18/2023, with a total of 11,537 and 3,463 shares respectively, both purchased with cash from the issuer. This planned sale follows a history of selling 75,000 shares over the past three months, generating total gross proceeds of $592,415.84. The notice of the upcoming sale was filed on the same date as the planned sale, with the initial plan adoption or instruction given on 03/01/2024.

Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 08/14/2024, with an aggregate market value of $95,251.36. The shares were acquired through stock option exercises on 06/14/2023 and 07/18/2023, with a total of 11,537 and 3,463 shares respectively, both purchased with cash from the issuer. This planned sale follows a history of selling 75,000 shares over the past three months, generating total gross proceeds of $592,415.84. The notice of the upcoming sale was filed on the same date as the planned sale, with the initial plan adoption or instruction given on 03/01/2024.